|

Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier

ByPsychedelic Spotlight

Similar Posts

  • Big Pharma Steps Onto the Psychedelics Wagon

    Business, Learn

    The world of medicine is constantly evolving as more and more research is conducted and breakthroughs are made. One area that has been garnering a lot of attention lately is the use of psychedelics in mental health treatment. And it seems that Big Pharma is taking notice.

  • I Just SOLD Half My MINDMED Shares And I’m Crying 😢 (MMED / MNMD)

    Listen, Videos

    So I just sold about HALF of my MindMed shares. But BEFORE you all FREAK OUT AND UNSUBSCRIBE, watch the rest of this episode and I can ASSURE YOU, there’s some good reasons there and none of them are about me losing faith in MMED/MNMD.
    I love MindMed. My MMED holdings have more than 10Xed since the company IPOed and I will keep the rest of my MindMed holdings probably forever!

    Enjoy the episode!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Website: https://thepsychedelicinvestor.com/
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #MNMD #MindmedNews

  • Interview with Victoria and Joël, of Tandava Retreats

    Listen, Podcasts

    Swati sits down with leaders from Kaivalya Kollectiv, “a multifaceted company focusing on psychedelic wellness, education”, and more. She speaks with Victoria Wueshner, a 5-MeO-DMT Facilitator and the Founder of FIVE, and Joël Brierre, CEO of Kaivalya Kollectiv.